Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C14H22ClN3O2 · HCl · H2O
CAS Number:
Molecular Weight:
354.27
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
Product Name
Metoclopramide hydrochloride, United States Pharmacopeia (USP) Reference Standard
SMILES string
[Cl-].Clc1c(cc(c(c1)C(=O)NCCN(CC)CC)OC)N.O.[H+]
InChI
1S/C14H22ClN3O2.ClH.H2O/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H;1H2
InChI key
KJBLQGHJOCAOJP-UHFFFAOYSA-N
grade
pharmaceutical primary standard
API family
metoclopramide
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Application
Metoclopramide hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
Also, for use with USP monographs such as:
- Metoclopramide Tablets
- Metoclopramide Oral Solution
- Metoclopramide Injection
- Prazosin Hydrochloride
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Hazard Classifications
Acute Tox. 4 Oral
signalword
Warning
hcodes
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ray M Merrill et al.
BMC psychiatry, 13, 152-152 (2013-05-30)
To identify the incidence rate of spontaneous dyskinesia (SD) and tardive dyskinesia (TD) in a general population and to examine the association between dykinesia and potential risk factors (exposure to metoclopramide [MCP], antipsychotic drugs, and history of diabetes and psychoses).
Radwa A Mohamed et al.
The Journal of pharmacy and pharmacology, 65(11), 1607-1621 (2013-10-10)
The purpose of this study was to formulate and characterize metoclopramide solid lipid nanoparticles (MCP-SLNs) and incorporating it into suppository bases for treatment of nausea and vomiting, produced with chemotherapeutic agents, using one dose per day. MCP-SLNs was prepared using
Diana Egerton-Warburton et al.
Emergency medicine Australasia : EMA, 25(3), 207-212 (2013-06-14)
The study aims to determine if slow intravenous infusion of metoclopramide reduces the incidence of acute drug-induced akathisia (DIA) compared with intravenous bolus. A prospective, double-blind, double dummy trial of adult patients requiring intravenous metoclopramide in the ED. Participants were
Jian-qin Lv et al.
Trials, 14, 153-153 (2013-05-29)
The incidence of postoperative nausea and vomiting (PONV) is 50 to 79% after neurosurgery. Our study is designed to evaluate the efficacy of pericardium 6 (P6; also known as Neiguan) acupoint stimulation versus placebo, and versus routine antiemetic for the
Anastasios Koulaouzidis et al.
Current medical research and opinion, 29(9), 1171-1185 (2013-06-25)
The use of purging for bowel cleansing prior to small-bowel capsule endoscopy (SBCE) has now been established in clinical practice. Despite that, the number of incomplete SBCEs is still around 15-20%. To date, the use of prokinetics in SBCE -
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service